Biodelivery Sciences International reported $7.44M in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acelrx Pharmaceuticals ACRX:US $ -9664000 420K
Adamas Pharmaceuticals ADMS:US -9525000 5.45M
Alimera Sciences ALIM:US $ -2235000 2.41M
Antares Pharma ATRS:US $ 5.39M 707K
Biocryst Pharmaceuticals BCRX:US $ -51377000 1.03M
Biodelivery Sciences International BDSI:US $ 7.44M 5.08M
Cara Therapeutics CARA:US $ -23561000 101.85M
Cti Biopharma CTIC:US $ -17070000 2.27M
Daiichi Sankyo 4568:JP -25668000000 56.67B
Endo International Ordinary Shares ENDP:US $ 219.43M 43.78M
JAZZ PHA JAZZ:US 162.12M 11.3M
Johnson & Johnson JNJ:US $ 7580.4M 3038.4M
Knight Therapeutics Inc GUD:CN C$ -1815000 7.28M
Lannett LCI:US $ 2.85M 21.45M
Nektar Therapeutics NKTR:US $ -109392000 1.33M
Pacira Pharmaceuticals PCRX:US $ 21.31M 4.24M
Pfizer PFE:US $ 5757M 4605M
Revance Therapeutics RVNC:US $ -70012000 7.96M
Teva Pharmaceutical TEVA:IT 794M 12M